dc.date.accessioned | 2021-09-24T11:52:55Z | |
dc.date.available | 2021-09-24T11:52:55Z | |
dc.identifier.uri | https://fif.hebis.de/xmlui/handle/123456789/1450 | |
dc.description.abstract | As part of LexisNexis Legal & Professional we are a leading global provider of regulatory and business information and analytics that help professional customers make better decisions, increase productivity and serve clients better. Our leading products and services are used throughout the world and in virtually every industry and area of business. We serve customers in more than 175 countries with 10,000 employees worldwide, and are part of RELX Group. RELX Group is one of the constituents of the FTSE 100 Index, Financial Times Global 500 and Euronext 100 Index. | |
dc.rights | Attribution-ShareAlike 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by-sa/4.0/ | |
dc.subject | Financial Markets | |
dc.title | LexisNexis | |
dc.type | Research Data | |
dcterms.isReferencedBy | https://fif.hebis.de/xmlui/handle/123456789/2260?Globally Dangerous Diseases: Bad News for Main Street, Good News for Wall Street? | |
dc.subject.keywords | who alerts | |
dc.subject.keywords | investor sentiment | |
dc.subject.keywords | pharmaceutical industry | |
dc.subject.keywords | trading strategies | |
dc.subject.jel | G11 | |
dc.subject.jel | G14 | |
dc.subject.jel | I11 | |
dc.subject.topic1 | responsible | |
dc.subject.topic1 | spread | |
dc.subject.topic1 | list | |
dc.subject.topic2 | robust | |
dc.subject.topic2 | evidence | |
dc.subject.topic2 | affect | |
dc.subject.topic3 | kaplanski | |
dc.subject.topic3 | dayToDay | |
dc.subject.topic3 | pharmaceutical | |
dc.subject.topic1name | Trading and Pricing | |
dc.subject.topic2name | Fiscal Stability | |
dc.subject.topic3name | Saving and Borrowing | |
dc.identifier.url | https://bis.lexisnexis.co.uk/ | |